Therapeutic Group: Gastro Intestinal Disorders


Each Marlox fast dissolving tablet contains Magaldrate (Hydroxy-magnesium Aluminate) USP 400 mg.


Marlox is a basic magnesium aluminium compound (i.e. Hydroxymagnesium Aluminate), which neutralizes gastric acid extraordinarily quickly without raising the pH above 5-6. It also decreases the activity of pepsin in gastric secretion.


Marlox is indicated to relieve symptoms of dyspepsia, heartburn, acid indigestion, sour stomach, gastroesophageal reflux, hiatal hernia and flatulence. It is also prescribed in hyperacidity associated with peptic ulcers, gastritis and esophagitis. Magaldrate may be given to children if necessary.

Dosage & Administration

1-3 Marlox tablets, after meals and at bed time or as directed by the physician.

Side Effects

Constipation and diarrhea may occur.

Use in Pregnancy & Lactation

Pregnant women: Magaldrate may be used in pregnancy if indicated however one should avoid excessive dosage.
Lactating mother: Magaldrate may pass into breast milk but has not been reported to cause problem in nursing babies.

Commercial Pack

Marlox tablet : Box containing 20 blister strips of 10 tablets.